{"id":"W7037705081","doi":"","title":"Enanta Pharmaceuticals Reports Financial Results for its Fiscal Fourth Quarter and Year Ended September 30, 2014 - NASDAQ (NASDAQ01) News","year":2014,"lang":"en","type":"other","venue":"","topic":"Fossil Insects in Amber","field":"Agricultural and Biological Sciences","cited_by":0,"is_retracted":false,"has_abstract":false,"ca_institutions":"","funders":"","keywords":"Quarter (Canadian coin); Fiscal year; Revenue; Economic forecasting; Productivity","routes":{"ca_aff":false,"ca_fund":false,"ca_venue":false,"about_ca":true,"invisible_to_affiliation_only":true},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0004538194,0.0005194379,0.000646208,0.00003618657,0.0001393088,0.0001302663,0.0002609794,0.0007888035,0.009073129],"category_scores_gemma":[0.0002285921,0.0001978426,0.0002320337,0.0001162894,0.0001322454,0.00007280659,0.0001304948,0.0002975031,0.0007289752],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0000244233,"about_ca_system_score_gemma":0.00002363095,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0001726644,"about_ca_topic_score_gemma":0.002027802,"domain_scores_codex":[0.9971083,0.0001353492,0.0006433204,0.001071169,0.0003728325,0.0006689806],"domain_scores_gemma":[0.9986359,0.000369182,0.0004236326,0.0002134102,0.00006544236,0.0002924745],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","study_design_scores_codex":[0.00009727274,0.00005875375,0.0001195937,0.00004351075,0.00003297514,0.00002421509,0.00001606484,1.546866e-7,0.001923908,0.0001744118,0.9914253,0.006083865],"study_design_scores_gemma":[0.0006179109,0.0002792457,0.0008672362,0.00009854283,0.0000552,0.00004931159,0.00002019037,0.00004641154,0.000755378,0.000256581,0.9963623,0.0005917322],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","genre_codex":"other","genre_gemma":"other","genre_scores_codex":[0.002799853,0.0005161154,0.00002966424,0.001389747,0.001257232,0.001356336,0.0005237176,0.0003647478,0.9917626],"genre_scores_gemma":[0.01035688,0.0001696067,0.001106929,0.001397176,0.003783236,0.0001147179,0.0002822666,0.00003444552,0.9827548],"genre_candidate":"other","genre_consensus":"other","teacher_disagreement_score":0.009007848,"threshold_uncertainty_score":0.9918327,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.02652789601398922,"score_gpt":0.273885254168001,"score_spread":0.2473573581540117,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}